Growing Focus on Stem Cell Research Is Expected to Boost the Global Cell Culture Protein Surface Coating Market Through 2019
The Global Cell Culture Protein Surface Coating Market is expected to post a CAGR of 12.91% from 2014 to 2019, thanks to a growing focus on stem cell research, according to a new report from research firm TechNavio.
Stem cell therapy plays a vital role in the treatment of several serious diseases including neurodegenerative diseases, cardiac diseases and diabetes. Presently, it is most commonly used for bone marrow transplants.
Cell culture protein surface coating products help researchers improve the adhesion, proliferation and growth of cells being cultured for these treatments.
“The high potential of stem cells in the treatment of severe diseases has resulted in demand for advanced cell culture products for stem cell production and study,” says Faisal Ghaus, Vice President of TechNavio.
The latest report by TechNavio draws attention to animal-free synthetic protein surface coatings that have a broad range of applications in several areas, including biopharmaceutical production and other research. There has been a huge demand for these coatings from the pharmaceutical and biotechnology industries, as they reduces the risk of contamination.
“Many vendors like BD are focusing on the development of animal-free synthetic protein surface coating products so as to meet increasing industry demand,” says Ghaus.
Key Information Covered in the Report:
• Market segmentation, size and forecast through 2019
• Market Growth Drivers:
• Growing Focus on Stem Cell Research
• For a full detailed list, view the report.
• Market Challenges:
• Disadvantages of Animal-derived Protein Surface Coatings
• For a full detailed list, view the report.
• Market Trends:
• Animal-free Synthetic Protein Surface Coating
• For a full detailed list, view the report.
Key Questions Answered in this Report:
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
• Key Vendors:
• Becton, Dickinson and Co. (BD)
• Corning Inc.
• EMD Millipore Corp.
• Sigma-Aldrich Corp.
• Other Prominent Vendors:
• Abcam
• BioMedTech Laboratories
• Cedarlane Laboratories
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance